Health-related Quality of Life and Antihypertensive Medication Adherence Among Older Adults

Overview

Journal Age Ageing

Publisher Oxford University Press

Specialty Geriatrics

Date 2010 Jun 2

PMID 20513770

Citations 46

Authors

Elizabeth Winter Holt

Paul Muntner

Cara Jean Joyce

Larry Webber

Marie A Krousel-Wood

Affiliations

Soon will be listed here.

Abstract

Purpose: health-related quality of life (HRQOL) is an important psycho-social characteristic which may impact an individual's ability to manage their chronic disease. We examined the association between HRQOL and antihypertensive medication adherence in older adults.

Methods: participants were part of a cohort study of older adults enrolled in a managed care organisation and treated for hypertension (n = 2,180). Physical and Mental Component Summary Scores (PCS and MCS) of HRQOL were assessed using the RAND Medical Outcomes Study 36-item tool. Adherence to antihypertensive medication was assessed with the eight-item Morisky Medication Adherence Scale.

Results: the mean age of participants was 75.0 +/- 5.6 years, 69.3% were white, 58.5% were women and 14.1% had low antihypertensive medication adherence. Low HRQOL scores were associated with lower levels of antihypertensive medication adherence in older adults. After adjustment for covariates, those with low PCS and MCS scores were 1.33 (95% CI 1.01, 1.74) and 2.26 (95% CI 1.74, 2.97) times more likely, respectively, to have low antihypertensive medication adherence than those with PCS and MCS scores in the top 2 tertiles.

Conclusions: low HRQOL may be an important barrier to achieving high medication adherence.

Citing Articles

Pre-stroke Adherence to Hypertension Medications in a Bi-racial United States Stroke Belt.

Bruno A, Muppa J, Cabahug I High Blood Press Cardiovasc Prev. 2023; 30(4):333-336.

PMID: 37233948 DOI: 10.1007/s40292-023-00581-6.

Association between health-related quality of life and nonadherence to antihypertensive medication.

Kim K Nurs Open. 2023; 10(6):3570-3578.

PMID: 36598870 PMC: 10170916. DOI: 10.1002/nop2.1599.

A Critical Review of Medication Adherence in Hypertension: Barriers and Facilitators Clinicians Should Consider.

Hamrahian S, Maarouf O, Fulop T Patient Prefer Adherence. 2022; 16:2749-2757.

PMID: 36237983 PMC: 9552797. DOI: 10.2147/PPA.S368784.

Adverse Reaction of Acupuncture and Antihypertensive Drugs for Treatment of Essential hypertension: A Protocol for Bayesian Network Meta-Analysis.

Han J, Yang J, Du Y Comput Intell Neurosci. 2022; 2022:7397307.

PMID: 36045996 PMC: 9420606. DOI: 10.1155/2022/7397307.

Evaluating the socio-demographic, economic and clinical (SDEC) factors on health related quality of life (HRQoL) of hypertensive patients using EQ-5D-5L scoring algorithm.

Aslam N, Shoaib M, Bushra R, Asif S, Shafique Y PLoS One. 2022; 17(6):e0270587.

PMID: 35771842 PMC: 9246217. DOI: 10.1371/journal.pone.0270587.

References

Kim M, Han H, Hill M, Rose L, Roary M . Depression, substance use, adherence behaviors, and blood pressure in urban hypertensive black men. Ann Behav Med. 2003; 26(1):24-31. DOI: 10.1207/S15324796ABM2601_04. View

Williams G, Patrick H, Niemiec C, Williams L, Divine G, Lafata J . Reducing the health risks of diabetes: how self-determination theory may help improve medication adherence and quality of life. Diabetes Educ. 2009; 35(3):484-92. PMC: 2831466. DOI: 10.1177/0145721709333856. View

Martinez Y, Prado-Aguilar C, Rascon-Pacheco R, Valdivia-Martinez J . Quality of life associated with treatment adherence in patients with type 2 diabetes: a cross-sectional study. BMC Health Serv Res. 2008; 8:164. PMC: 2519069. DOI: 10.1186/1472-6963-8-164. View

Krousel-Wood M, Muntner P, Islam T, Morisky D, Webber L . Barriers to and determinants of medication adherence in hypertension management: perspective of the cohort study of medication adherence among older adults. Med Clin North Am. 2009; 93(3):753-69. PMC: 2702217. DOI: 10.1016/j.mcna.2009.02.007. View

Charlson M, Pompei P, Ales K, MacKenzie C . A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987; 40(5):373-83. DOI: 10.1016/0021-9681(87)90171-8. View

Chobanian A, Bakris G, Black H, Cushman W, Green L, Izzo Jr J . The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003; 289(19):2560-72. DOI: 10.1001/jama.289.19.2560. View

Schoenthaler A, Ogedegbe G, Allegrante J . Self-efficacy mediates the relationship between depressive symptoms and medication adherence among hypertensive African Americans. Health Educ Behav. 2007; 36(1):127-37. DOI: 10.1177/1090198107309459. View

Pippalla R, Chinburapa V, Duval R, Akula R . Interrelationships of quality of life, compliance, clinical outcomes and life satisfaction: a cross-sectional study on hypertensive geriatrics. J Clin Pharm Ther. 2009; 22(5-6):357-69. DOI: 10.1111/j.1365-2710.1997.tb00019.x. View

Ong K, Cheung B, Man Y, Lau C, Lam K . Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004. Hypertension. 2006; 49(1):69-75. DOI: 10.1161/01.HYP.0000252676.46043.18. View

10.

Coyne K, Davis D, Frech F, Hill M . Health-related quality of life in patients treated for hypertension: a review of the literature from 1990 to 2000. Clin Ther. 2002; 24(1):142-69. DOI: 10.1016/s0149-2918(02)85012-3. View

11.

Gandek B, Sinclair S, Kosinski M, Ware Jr J . Psychometric evaluation of the SF-36 health survey in Medicare managed care. Health Care Financ Rev. 2004; 25(4):5-25. PMC: 4194895. View

12.

Sung J, Nichol M, Venturini F, Bailey K, McCombs J, Cody M . Factors affecting patient compliance with antihyperlipidemic medications in an HMO population. Am J Manag Care. 1999; 4(10):1421-30. View

13.

Krousel-Wood M, Islam T, Webber L, Re R, Morisky D, Muntner P . New medication adherence scale versus pharmacy fill rates in seniors with hypertension. Am J Manag Care. 2009; 15(1):59-66. PMC: 2728593. View

14.

Hays R, Sherbourne C, Mazel R . The RAND 36-Item Health Survey 1.0. Health Econ. 1993; 2(3):217-27. DOI: 10.1002/hec.4730020305. View

15.

Sikka R, Xia F, Aubert R . Estimating medication persistency using administrative claims data. Am J Manag Care. 2005; 11(7):449-57. View

16.

Wang P, Bohn R, Knight E, Glynn R, Mogun H, Avorn J . Noncompliance with antihypertensive medications: the impact of depressive symptoms and psychosocial factors. J Gen Intern Med. 2002; 17(7):504-11. PMC: 1495082. DOI: 10.1046/j.1525-1497.2002.00406.x. View

17.

Trivedi R, Ayotte B, Edelman D, Bosworth H . The association of emotional well-being and marital status with treatment adherence among patients with hypertension. J Behav Med. 2008; 31(6):489-97. PMC: 3746832. DOI: 10.1007/s10865-008-9173-4. View

18.

Krousel-Wood M, Thomas S, Muntner P, Morisky D . Medication adherence: a key factor in achieving blood pressure control and good clinical outcomes in hypertensive patients. Curr Opin Cardiol. 2004; 19(4):357-62. DOI: 10.1097/01.hco.0000126978.03828.9e. View

19.

Hopman W, Harrison M, Coo H, Friedberg E, Buchanan M, VanDenKerkhof E . Associations between chronic disease, age and physical and mental health status. Chronic Dis Can. 2009; 29(3):108-16. View

20.

DiMatteo M, Lepper H, Croghan T . Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med. 2000; 160(14):2101-7. DOI: 10.1001/archinte.160.14.2101. View